AstraZeneca Pharmaceutical Industry Fellowship Program 2022

1

AstraZeneca Pharmaceutical Industry Fellowship Program 2022

Rutgers Institute for Pharmaceutical Industry Fellowships

2

A Message from our Executive Sponsors

On behalf of AstraZeneca and the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, we would like

to thank you for your interest in our fellowship program. Our partnership with the Rutgers Institute for Pharmaceutical Industry

Fellowships allows us to participate in the growth and development of the next generation of industry-based pharmacists.

As a global biopharmaceutical company, AstraZeneca provides innovative medicines for some of the world’s most serious diseases.

Pioneering new scientific ideas means never settling for second best and always being ready to challenge the status quo. That’s

why we look for people who share our thirst for knowledge, our love of innovation, and our ambitious approach to self-improvement.

If that’s you, why not discover everything that makes us a destination of choice for some of the brightest people in the global

biopharmaceutical industry?

We value the talents and skills of our 65,000 employees in more than 100 countries. Our people strategy, which supports our strategic

priority of being a great place to work, is built around four key pillars: build and develop organizations and capabilities; develop a

strong and diverse pipeline of leaders; drive a vibrant, high-performing culture; and generate a passion for people development.

This means we place emphasis on effective leadership, the acquisition and retention of great talent, setting clear targets, open

lines of communications, excellent learning and development opportunities, and a healthy, safe and energizing workplace – within

a performance culture in which diversity is valued and individual success depends solely on personal merit and performance.

Your fellowship experience at AstraZeneca will yield a broad overview of key functions within the biopharmaceutical

industry through real-world experiences and learnings. You will have the opportunity to engage with dedicated

professionals who are pushing the boundaries of science to deliver life-changing medicines.

From all of us at AstraZeneca, we wish you much success and hope you strongly consider the AstraZeneca

Fellowship Program as an investment in your personal career development and growth.

3

About AstraZeneca

Our Purpose and Values

We Follow the Science

• I am curious and push the boundaries of science

• I am creative in how I work with partners and collaborators

We Put Patients First

• I am proud to serve patients and consider them in every decision I take

• I strive to understand patients’ needs and act accordingly

We Play To Win

• I am determined to make the right choices to win

• I build high performing teams that collaborate across the enterprise

We Do The Right Thing

• I am accountable for my actions and the success of AZ

• I speak up to ensure that all we do is aligned to our values

We Are Entrepreneurial

• I am brave, resilient and take smart risks

• I act with urgency and simplify the way work gets done

Pascal Soriot, CEO

Our values guide everything we do and underpin

the delivery of our Global Scorecard targets.

4

Available AstraZeneca Fellowship Positions

Wilmington, DE(Greater Philadelphia Area)

Gaithersburg, MD(Greater DC Area)

• US Marketing, Immuno-Oncology

• US Marketing, ADC Oncology

• Global Patient Safety, Oncology

• Global Regulatory Labeling Strategy

• Oncology Regulatory Science and Strategy (ORSS), Global Regulatory Affairs

• Medical Information & Medical Affairs Strategy, Breast Cancer

• Medical Information & Medical Affairs Strategy, Respiratory Biologics

• Medical Information & Medical Affairs Strategy, Renal

5

Madelaine Ambrose,PharmD, RPhUS Antibody Drug Congjugate

Marketing, Oncology

Purdue University

Jon Apple,PharmDHEOR, Oncology

University of Florida

Stacy Ndubuizu,PharmDGlobal Labeling Strategy

Mercer University

Mivielis Rivera,PharmD, RPhMedical Information/Medical

Strategy, Oncology

University of North Texas

Anthony Corry,PharmD, RPhGlobal Patient Safety, Oncology

Temple University

Sheri Saka,PharmDGlobal Regulatory Affairs,

Oncology

University of Toledo

Kara Glover,PharmDMedical Information/Medical

Strategy, Oncology

Florida A&M

Amanda Cline,PharmDMedical Information/Medical

Strategy, Renal

Thomas Jefferson University

Rija Saleem,PharmDMedical Information/Medical

Strategy, CVMD

University of Charleston

Current Fellows (2nd Year)

Medical Affairs US Marketing Regulatory and Safety

6

Daniel WongPharmDAccess Strategy, US Oncology

University of Florida

Daniel StrengPharmDPatient Advocacy, US Oncology

University of Arizona

Sheena Dupuy PharmDMedical Information/Medical

Affairs Strategy, Immuno-

Oncology

Howard University

Ananya MuraliPharmDOncology Regulatory Strategy and

Sciences (ORSS)

University of Washington

Carl Lowe,PharmDMedical Information/Medical

Science Liaison/Medical Affairs

Strategy, Respiratory

University of Mississippi

Current Fellows (1st Year)


7

Trace WilkinsonPharmDUS Patient Safety

Florida A&M University

Current Fellows (1st Year)


Stefan EapenPharmDMedical Information/Medical

Strategy, Oncology

Albany College of Pharmacy and

Health Sciences

Zulikhat SegunmaruPharmDHealth Economics and Outcomes

Research, Oncology

Howard University

Morine AbdelmesehPharmDPromotional Regulatory Affairs,

Oncology/CVMD

St. John’s University

Jennifer Huang,PharmDMedical Information/Medical

Strategy, CVMD

California Northstate University

8

Fellowship Steering Committee

Jose Argueta, PharmDDirector of Medical Alignment, Oncology

Corey Fang, PharmDSenior Medical Information

Manager, Cardiovascular

Andrew Fariello, PharmDVice President, Global Medical

Capabilities, Oncology Business Unit

Executive Sponsor

Kevin KrauseVP Strategy and Operations – Medical

Pharmaceuticals

Executive Sponsor

Alex Schuster, PharmDSenior Marketing Manager, Oncology

9

Available Fellowships

9

10


Overview

The Immuno-Oncology Pharmacy Fellow will be responsible for the strategic planning and tactical execution

of initiatives focused on Improving Multi-Disciplinary Team coordination. Fellow’s responsibility will be to

ensure that long term patient care plans are followed and to ensure the best possible outcomes for patients

living with lung cancer.

The fellow will be a key member of the immuno-oncology marketing team and work in close partnership with

marketing colleagues across the entire Immuno-Oncology franchise as well as the broader oncology

business unit. This position is based at our Gaithersburg, MD campus, headquarters for our US Oncology

business, as well as the US Commercial Center for multiple Therapeutic Areas of our Global Product and

Portfolio Strategy businesses.

Objectives

• Learn both the clinical and business elements of US franchise marketing in the immuno-oncology space

• Develop new assets through innovation, collaboration with cross functional partners, and ownership

through the Medical/Legal Review process

• Key areas of focus will include, multi-disciplinary coordination focusing on Pharmacists, Nurse/Nurse

Navigators, In-hospital IO Initiation, and improving duration of therapy through adverse event

management and care team coordination.

• Build strategic and tactical plans for future IO indications or new launches pending data

10

US Marketing - Immuno-Oncology

Fellowship Details

Length: 2 years

Location: Gaithersburg, MD

Positions: 1

11


Overview

The fellow will spend most of their time supporting the US ADC oncology

franchise marketing team and has the opportunity to pursue additional projects

with other cross-functional teams, depending on personal goals.

Fellowship Objectives:

• Learn both the clinical and business elements of US franchise marketing in the

ADC space, across tumor types

• Develop new assets through innovation, collaboration with cross functional

partners, and ownership through the medical, legal, regulatory review process

• Build strategic and tactical plans for future indications in AstraZeneca’s

oncology portfolio

11

US Marketing – Antibody-Drug Conjugates Oncology

Fellowship Details

Length: 2 years


Positions: 1

12


First Year Objectives:

The target is to develop the fellow’s core competencies and leadership capabilities in global patient safety.

Throughout the fellowship period, the fellow will be given the opportunity to be involved in the following:

• Gain an understanding on the foundation of pharmacovigilance activities and key roles for global

patient safety colleagues

• Support routine pharmacovigilance activities including signal detection, authoring of periodic reports

and core safety documents, contribution to safety strategy for early and late development products

• Ability to reference and apply key pharmacovigilance guidelines use in production of core PV

documents

• Gain a deep understanding of the Safety Strategy and Management Team Lead (SSaMTL) role and

key responsibilities within this position

• Other activities as discussed and agreed with the line manager / preceptor / mentor

Second Year Objectives:

Build on competencies gained in year 1 to:

• Lead pharmacovigilance activities for an early development product(s) as a SSaMTL

• Lead safety contribution in coordination with the GSP for health authority interactions and/ or

submission activities

• Contribute to process improvement activities within the global patient safety and patient safety center

of excellence organizations

• Collaborate with cross functional teams to lead safety contribution and strategy

• Attend a major Oncology area related conference to obtain relevant disease state and safety

knowledge in support of Global Patient Safety teams

• Be provided rotational opportunities in other functional areas such as Chemistry Manufacturer and

Control (CMC), Global Medical Affairs (GMA), Clinical Development, Global Regulatory Affairs and

Global Labeling Group (GLG) knowledge

12

Global Patient Safety - Oncology

Fellowship Details

Length: 2 years


Positions: 1

13



The target is to develop the fellow’s core competencies and leadership capabilities in strategic labeling

development. Throughout the fellowship period, the fellow will be given the opportunity to be involved in the

following:

• Gain an understanding of the labeling development process, the end-to-end labeling lifecycle, and the role of

the Global Labeling Strategist

• Support project teams and Global Labeling Strategist(s) with important labeling precedence for strategic

decision-making

• Enhance written and verbal communication skills

• Opportunities to be proficient in project management at the anticipated level

• Other activities as discussed and agreed with the line manager / preceptor


Build on competencies gained in Year 1:

• Become proficient in understanding and applying labeling-related regulations and guidance for the US and

EU, and concepts related to the Core Data Sheet

• Build necessary competencies to effectively lead Product Labeling Teams (PLTs) in the development and/or

maintenance of high-quality Core Prescribing Information, EU Quality Review Documents (EU QRDs), US

Prescribing Information (USPIs), Patient Package Inserts (PPIs), Medication Guides (MGs), and Instructions

for Use (IFUs)

• Build regulatory intelligence and analysis skills in support of labeling brand differentiation strategy

• Interact with colleagues from various departments to learn about the contributions of key stakeholder

functions to labeling activities

• Be provided rotational opportunities in other functional areas such as Global Medical Affairs (GMA), Patient

Safety (PS) and Global Regulatory affairs.

• Build competencies in leadership, negotiation skills, relationship and consensus building, critical information

seeking, and multi-cultural awareness and sensitivity

• Provide mentorship to junior staff (toward the end of the fellowship)13

Global Regulatory Labeling Strategy

Fellowship Details

Length: 2 years


Positions: 1

14



The target is to develop the fellow’s core competencies and leadership capabilities in regulatory affairs.

Throughout the fellowship period, the fellow will be given the opportunity to be involved in the following:

• Gain experience with operational and strategic aspects of global oncology regulatory affairs

• Support project teams and Global Regulatory Lead (GRL) with important regulatory precedent for

strategic decision-making

• Opportunities to be proficient in project management at the anticipated level

• Provide mentorship to junior staff (toward the end of his fellowship)

• Other activities as discussed and agreed with the line manager / preceptor / mentor


•Build on competencies gained in year 1 to:

• Learn key aspects of global regulations to apply regulatory requirements to the development,

approval, and maintenance of drugs and biologics

• Gain experience in developing regulatory strategy

• Participate in health authority interactions and assess regulatory risks

• Work with Regulatory Project Management to execute and manage the end-to-end delivery of

regulatory submissions for global clinical trials

• Work with matrix team members to identify solutions that meet regulatory requirements as well as

commercial objectives

• Be provided rotational opportunities in other functional areas such as Chemistry Manufacturer and

Control (CMC), Global Medical Affairs (GMA), Clinical Development, Patient Safety (PS) and Global

Labeling Group (GLG) knowledge

• Attend a major Oncology area or Regulatory Affairs related conference to obtain relevant disease

state knowledge and regulatory science updates in support of ORSS teams

• Gain exposure to interactions between ORSS, other R&D and non-R&D functions 14

Oncology Regulatory Science and Strategy (ORSS)

Global Regulatory Affairs

Fellowship Details

Length: 2 years


Positions: 1

15



• Provide balanced scientific responses to unsolicited requests from healthcare professionals, and

internal and external customers regarding AstraZeneca products and adverse event and Product

Quality Control (PQC) reporting, including both US & Global

• Research medical literature, evaluate scientific data and develop evidence-based medical content in

standard responses, slide decks, FAQs etc.

• Responsible for medical review of advertising and promotional material to ensure scientific accuracy,

regulatory, and commercial objectives

• Participate in collaborative projects with Marketing, Training, other Medical Affairs functions, including

Global, and Sales to provide scientific support and education to various medical and sales teams

• Participate scientific congress activity (materials, attendance, medical information booth, disease

information and competitive insights etc.)

• Gain an understanding of the laws, regulations, and policies required to help ensure legal and ethical

interactions with health care professionals


• Develop understanding of medical affairs activities and functions, including medical strategy and

execution, launch planning, and congress strategies.

• Participate in strategic planning and execution based on medical unmet need based on perspective of

patients, providers and payers

• Participate in medical strategy execution through engagement with medical affairs cross functional

teams including field medical/medical payer, medical information, health outcomes, and medical

education grants office

• Interact with other AZ departments to gain understanding of how these functions inform medical

affairs activities (marketing, global medical, clinical development, legal, regulatory)15

Medical Information & Medical Affairs Strategy, Breast

Cancer

Fellowship Details

Length: 2 years


Positions: 1

16


Overview

This fellow will be an integral part of the team, gain hands-on experience and will be trained and developed to manage

responsibilities similar to those in current full-time positions within AZ. This 2-year fellowship will have a MI functional focus with a

strong Medical Strategy and execution component within the Respiratory Biologics and Inhaled Therapeutic Area.

First Year - Medical Information Objectives:

• Develop an understanding of global and local medical strategy development and execution as it related to MI deliverables

• Research medical literature and evaluate scientific data to develop evidence-based medical global and US content (i.e.,

standard responses, slide decks, FAQs)

• Provide balanced scientific responses to unsolicited requests from healthcare professionals, and internal and external

customers regarding AZ products

• Responsible for medical review of advertising and promotional material to ensure scientific accuracy, regulatory and

commercial objectives

• Collaborative projects with Marketing, Training, other Medical functions and Sales to provide scientific support and education to

various medical and sales teams

• Participate in scientific congress activity (materials, attendance, medical information, disease information and competitive

insights etc.)

• Gain an understanding of the laws, regulations and policies required to help ensure legal and ethical interactions with health

care professionals

Second Year - Medical Affairs Strategy Objectives:

• Develop an understanding of the US medical strategy development and execution within Respiratory Biologics Program

• Participate in medical strategy execution through engagement with field medical, medical information, publication strategy,

medical education, health policy, and outcomes teams

• Participate in strategic/launch planning based on the unmet medical needs from the perspectives of patients, providers, and

payers

• Interact with marketing, clinical development, global medical, legal, and regulatory affairs as they relate to US Medical daily

activities and special projects (e.g., advisory boards, congress planning, vendor management)

• Gain practical experience in providing information to external and internal stakeholders that enhances the appropriate use of

AZ’s products by responding to customer inquiries with balanced scientific information and delivering scientific information that

clinically differentiates AZ’s products.

• Learn about standard internal processes and regulatory/compliance requirements as well as developing expertise in disease

state management, emerging therapies and the competitive landscape

16

Medical Information and Medical Strategy— Respiratory

Biologics

Fellowship Details

Length: 2 years

Location: Wilmington, DE

Positions: 1

17


Overview

• Complete all required Compliance Training

• Complete Renal Disease and Product training

• Successfully complete Prescribing Information assessment and/or verbal product certification

• Demonstrates continuous professionalism and respect

• Positive and cooperative attitude- willing to take on new projects to help others and learn all aspects of the function

• Develop networking/relationship building skills to connect with individuals across all of AstraZeneca’s cross-functional

teams (including AZ functional leads and other AZ fellows) and the Rutgers fellowship community

Medical Information (MI) Objectives:

• Provide fair-balanced scientific responses to unsolicited requests from healthcare professionals in the US and develop

global documents for local market use regarding AstraZeneca products

• Research medical literature and evaluate scientific data to develop evidence-based medical content in standard

responses (including verbal), slide decks, and other Medical Affairs materials (including payor assets such as AMCP

dossier)

• Perform medical review of advertising and promotional material to ensure scientific accuracy

• Develop scientific content, including slide decks and other resources such as medical Q&As, to support the field in

Medical Affairs

• Participate in collaborative projects with Marketing, other Medical Affairs functions, and Sales to provide scientific

support and education to various field medical and sales teams on product and disease state knowledge

• Participate in scientific congress activities, including materials development and Medical Information booth staffing

Medical Affairs (MA) Strategy Objectives:

• Assist with development and execution of congress and insight strategy

• Understand the role of a medical communications agency for MA activities

• Participate in execution of medical strategy through engagement with field medical, medical information, scientific

training, medical education, promotion regulatory affairs and payer evidence teams as they relate to US Medical Affairs

activities 17

Medical Information and Medical Affairs Strategy—

Renal

Fellowship Details

Length: 2 years

Location: Wilmington, DE

Positions: 1

18

In 1984, at Rutgers, The State University of

New Jersey, the Ernest Mario School of

Pharmacy and two pharmaceutical

companies began a collaborative pilot

program to evaluate the potential

contributions of clinically-trained pharmacists

within a pharmaceutical industry practice

setting. Following the successful pilot, the

Rutgers Pharmaceutical Industry Fellowship

(RPIF) Program grew significantly and

expanded to include 21 companies within the

pharmaceutical and biopharmaceutical

industry and approximately 300 Fellows.

FOUNDING

In 2002, Dr. Ernest Mario generously provided an endowment to

establish the Institute for Pharmaceutical Industry Fellowships

to enhance and promote the role of pharmacists in industry through

the RPIF Program. The Institute staff members:

• Provide leadership and administrative support;

• Promote quality, communication, and scholarly activity; and

• Arrange specialized fellowship training opportunities within the

pharmaceutical and biopharmaceutical industry.

In 2018, our program expanded to offer interdisciplinary fellows’

training by adding select physician fellowship opportunities to our

well-established program.

INSTITUTE FOR

PHARMACEUTICAL

INDUSTRY FELLOWSHIPS

The RPIF Program has thrived under the leadership

of the founder, Dr. Joseph A. Barone, Dean and

Professor II of the Ernest Mario School of Pharmacy,

Dr. Carolyn Seyss, the Director for the Institute for

Pharmaceutical Industry Fellowships, and Dr.

Michael Toscani as Director Emeritus.

LEADERSHIP

More than 1,300 Post-Doctoral Fellows have completed the RPIF Program,

most of whom are experiencing influential and rewarding careers in the

pharmaceutical and biopharmaceutical industry throughout the US and

abroad. The RPIF Program has Preceptors and Mentors from industry who

share their knowledge and experiences with the Fellows through an intense

but closely-guided training program. Assignments and projects are

challenging, meaningful, and designed to enhance understanding of the

pharmaceutical and biopharmaceutical industry and the Fellow’s functional

area(s). Our goal is to provide the environment for Fellows to build the

foundations for their careers as future leaders in the industry.

FELLOWS

Rutgers Pharmaceutical Industry Fellowship Program History

19

Professional Development SeriesAll Fellows gather once monthly as a group to participate in the Professional Development Day (PDD) series, an important component of their training that

complements the hands-on experience provided at the partner companies. The PDDs are steered by a committee of Fellows and are designed to enhance

the Fellows’ leadership skills such as emotional intelligence, communication, critical decision making, and presentation skills. Fellows develop skill sets

under the guidance of external trainers. PDDs also provide general knowledge about various aspects of drug development/commercialization and issues

facing the pharmaceutical and biopharmaceutical industry and promote connectivity and a sense of community among Fellows and alumni from different

companies and disciplines.

The Fellows can learn from each other through individual and group presentations and debates on topics and issues related to the pharmaceutical and

biopharmaceutical industry. The dynamic forum of PDD provides an opportunity for open discussion and debate among fellows, Rutgers faculty, and

company Preceptors. In addition, outside experts provide training and professional development in a variety of areas (e.g., tools for corporate success;

professional writing, presentations, meeting facilitation, negotiating, influencing, networking, and conflict resolution skills; giving and receiving feedback;

and business and dining etiquette). Other PDD guest speakers include senior industry executives, patient advocacy groups, and successful RPIF Program

alumni who share their insights and experiences. Importantly, PDDs provide an excellent opportunity for Fellows to interact with each other and develop

lasting personal friendships and a strong professional network of Fellows, faculty, alumni, and other industry executives.

About the Rutgers Component

20

Key Program Features

Family of Leading Companies–Partners include several of the top global

pharmaceutical and biopharmaceutical companies.F

OOutstanding Alumni Track Record–Over 1,300 alumni hold prominent positions

at many leading companies.

SStrong Network—Fellows develop valuable, lasting connections with each other,

alumni, Preceptors, and faculty.

TTrusted and Proven Since 1984 — the Rutgers Fellowship Program is nationally

recognized, trusted, and proven as the key pathway to industry for pharmacists

as future leaders

EEnhanced Career Development – Breadth of experiences informs career path

choices and increasingly challenging assignments build depth of experience,

enhancing the potential for accelerated career paths.

RRigorous Academic Component–Rutgers affiliation provides academic and

professional development opportunities.

Rutgers, The State University of New

Jersey, with over 71,000 students in its

three campuses, is one of the major

state university systems in the United

States. The New Jersey College of

Pharmacy was founded in 1892 and

was incorporated into the University in

1927. The Ernest Mario School of

Pharmacy is part of Rutgers Biomedical

and Health Sciences, the only state

school of pharmacy in New Jersey, with

approximately 1,350 students in its

Doctor of Pharmacy degree program.

The Rutgers Ernest Mario School of

Pharmacy is located on the University’s

main science and technology campus

in Piscataway, New Jersey. Because of

its relationship with and, for most, close

proximity to the nation's leading


companies, the Ernest Mario School of

Pharmacy and the RPIF Program are

uniquely capable of providing fellows

with advanced training in the


industry.

The Rutgers Pharmaceutical Industry Fellowship Program FOSTERs the growth and

development of future pharmaceutical and biopharmaceutical industry professionals and

leaders through the following key program features:

21

Application Process and Eligibility RequirementsPharmacy Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationally competitive

basis. Candidates must have completed a Doctor of Pharmacy degree from an ACPE-accredited institution before July 1

of the fellowship term.

How to Apply:

Interviewing is conducted on a rolling basis. Interested candidates may submit their application and supporting

materials (letter of intent, curriculum vitae, and three letters of recommendation) during October 2021 by visiting

our website at: https://pharmafellows.rutgers.edu

All application materials must be submitted electronically to the RPIF Website.

21

Required Items Deadline*

Curriculum Vitae (CV) November 1st

Letter of Intent (LOI) November 1st

3 Letters of Recommendation

(LORs)

December 5th

*Candidates are considered on a rolling basis. Submission of materials prior to deadline is strongly

encouraged.

Joseph A. Barone,

Pharm.D., F.C.C.P.

Dean and Professor II

Ernest Mario School of Pharmacy

Rutgers University

Carolyn Seyss, Pharm.D.

Fellowship Director and RPIF

Alumna

Institute for Pharmaceutical

Industry Fellowships

Ernest Mario School of

Pharmacy

Michael Toscani, PharmD.Research Professor,

Fellowship Director Emeritus

Institute for Pharmaceutical Industry

Fellowships


Your Letter of Intent & Letters of Recommendation should be addressed to:

Joseph A. Barone, Pharm.D., F.C.C.P.

Dean and Professor II


Rutgers, The State University of New Jersey

160 Frelinghuysen Road

Piscataway, NJ 08854-8020

https://pharmafellows.rutgers.edu/

22

In Memory of Our Beloved Fellowship Program Founder,

Debra S. Weintraub, Pharm.D.

AstraZeneca Pharmaceutical Industry Fellowship Program 2022

Documents

Transcript of AstraZeneca Pharmaceutical Industry Fellowship Program 2022